{"count": 3, "results": [{"_id": "37681467", "pmid": 37681467, "title": "Association between statins exposure and risk of skin cancer: an updated meta-analysis.", "journal": "Int J Dermatol", "authors": ["Wang D", "Dai S", "Lou D", "Wang T", "Wang S", "Zheng Z"], "date": "2023-09-08T00:00:00Z", "doi": "10.1111/ijd.16816", "meta_date_publication": "2023 Sep 8", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.438, "text_hl": "Further subgroup analysis of the subtypes of statins revealed that compared with the non-exposed group, exposure to @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ (OR: 1.18, P = 0.048) or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (OR: 1.11, P < 0.001) was a risk factor for @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@skin cancer@@@. ", "citations": {"NLM": "Wang D, Dai S, Lou D, Wang T, Wang S, Zheng Z. Association between statins exposure and risk of skin cancer: an updated meta-analysis. Int J Dermatol. 2023 Sep 8;():. PMID: 37681467", "BibTeX": "@article{37681467, title={Association between statins exposure and risk of skin cancer: an updated meta-analysis.}, author={Wang D and Dai S and Lou D and Wang T and Wang S and Zheng Z}, journal={Int J Dermatol}}"}}, {"_id": "39974652", "pmid": 39974652, "title": "Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.", "journal": "ACS Pharmacol Transl Sci", "authors": ["Martins M", "Veiga F", "Paiva-Santos AC", "Pires PC"], "date": "2025-01-23T00:00:00Z", "doi": "10.1021/acsptsci.4c00679", "meta_date_publication": "2025 Feb 14", "meta_volume": "8", "meta_issue": "2", "meta_pages": "308-338", "score": 50253.06, "text_hl": "Drug Repurposing and Nanotechnology for Topical @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@Skin Cancer@@@ Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.", "citations": {"NLM": "Martins M, Veiga F, Paiva-Santos AC, Pires PC. Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects. ACS Pharmacol Transl Sci. 2025 Feb 14;8(2):308-338. PMID: 39974652", "BibTeX": "@article{39974652, title={Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.}, author={Martins M and Veiga F and Paiva-Santos AC and Pires PC}, journal={ACS Pharmacol Transl Sci}, volume={8}, number={2}, pages={308-338}}"}}, {"_id": "26742009", "pmid": 26742009, "pmcid": "PMC4742576", "title": "Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative", "journal": "Br J Cancer", "authors": ["Wang A", "Stefanick ML", "Kapphahn K", "Hedlin H", "Desai M", "Manson JA", "Strickler H", "Martin L", "Wactawski-Wende J", "Simon M", "Tang JY"], "date": "2016-02-02T00:00:00Z", "doi": "10.1038/bjc.2015.376", "meta_date_publication": "2016 Feb 2", "meta_volume": "114", "meta_issue": "3", "meta_pages": "314-20", "score": 50058.0, "text_hl": "...The first two @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ trials suggested an association with @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@NMSC@@@ seen more often in treatment groups. ", "citations": {"NLM": "Wang A, Stefanick ML, Kapphahn K, Hedlin H, Desai M, Manson JA, Strickler H, Martin L, Wactawski-Wende J, Simon M, Tang JY. Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative Br J Cancer. 2016 Feb 2;114(3):314-20. PMID: 26742009", "BibTeX": "@article{26742009, title={Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative}, author={Wang A and Stefanick ML and Kapphahn K and Hedlin H and Desai M and Manson JA and Strickler H and Martin L and Wactawski-Wende J and Simon M and Tang JY}, journal={Br J Cancer}, volume={114}, number={3}, pages={314-20}}"}}]}